Table 1.
Subjects and studies included
| Characteristics | Protocol (after fasting period) | n Male/Female | Notes | References |
|---|---|---|---|---|
| Lean | OGTT and euglycemic clamp | 12/3 | No blood flow measurements | (8, 17) |
| Lean and overweight | Alcohol ingestion and control study | 5/2 | No blood flow measurements; two visits, short time apart | (18) |
| Lean and obese | Mixed meal ingestion | 13/14 | (6, 7) | |
| Lean and obese | High-fat meal ± insulin infusion | 6/1 | (21) | |
| Lean and obese | Controls for manipulation of GH, cortisol | 17/7 | (56–59) | |
| Lean and overweight | Intravenous lipid infusion | 6/0 | (55) | |
| Lean and overweight | Mixed meal/studies of TG-rich lipoprotein metabolism | 7/0 | (35) | |
| Lean and obese | Studies of structured TG metabolism | 4/15 | Two visits, short time apart | (65, 66) |
| Lean and overweight | Ingestion of meal rich in n-3 fatty acids | 9/0 | (64) | |
| Lean and overweight | Intralipid: oral vs. iv administration | 4/2 | Two visits, short time apart | (13) |
| Lean and overweight | Controls for study of familial combined hyperlipidemia | 5/5 | (11) | |
| Lean and obese | Dietary starch supplementation | 4/6 | (53) | |
| Lean and obese | Pulsatility of lipolysis | 6/3 | (33) | |
| Lean and obese | Studies of Pparg genetic variation | 42/0 | (68, 69) | |
| Lean and obese | Controls for study of insulin-resistant men | 10/0 | (2, 3) | |
| Lean and obese | Studies of metabolism over 24-h periods | 19/3 | (43, 54) | |
| Lean and overweight | Studies of abdominal vs. femoral fat metabolism | 8/4 | (44) | |
| Lean and obese | Various | 26/30 | Unpublished |
GH, growth hormone; TG, triacylglycerol; OGTT, oral glucose tolerance test.